We provide a theoretical and empirical analysis of the link between financial and real health care markets. We document a "medical innovation premium" of 4-6% annually for equity of medical firms and analyze the implications it has for the growth of the health care sector. We interpret the...

We develop a pair of risk measures, health and mortality delta, for the universe of life and health insurance products. A life-cycle model of insurance choice simplifies to replicating the optimal health and mortality delta through a portfolio of insurance products. We estimate the model to...

We study a new data set of prices of traded dividends with maturities up to 10 years across three world regions: the US, Europe, and Japan. We use these asset prices to construct equity yields, analogous to bond yields. We decompose these yields to obtain a term structure of expected dividend...